The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 29, 2022
Filed:
Jul. 06, 2021
Applicant:
Vanda Pharmaceuticals Inc., Washington, DC (US);
Inventors:
Marlene Michelle Dressman, Germantown, MD (US);
John Joseph Feeney, Olney, MD (US);
Louis William Licamele, Potomac, MD (US);
Mihael H. Polymeropoulos, Potomac, MD (US);
Assignee:
VANDA PHARMACEUTICALS INC., Washington, DC (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/343 (2006.01); A61K 31/00 (2006.01); A61K 45/06 (2006.01); A61K 31/15 (2006.01); A61K 31/277 (2006.01); A61K 31/496 (2006.01); G01N 30/72 (2006.01); G16H 50/20 (2018.01); G01N 33/74 (2006.01); G01N 33/68 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/343 (2013.01); A61K 9/006 (2013.01); A61K 9/0053 (2013.01); A61K 31/00 (2013.01); A61K 31/15 (2013.01); A61K 31/277 (2013.01); A61K 31/496 (2013.01); A61K 45/06 (2013.01); G01N 30/7233 (2013.01); G01N 33/6893 (2013.01); G01N 33/74 (2013.01); G16H 50/20 (2018.01); G01N 2800/2864 (2013.01);
Abstract
Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.